© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, BioMarin Pharmaceutical Inc. (BMRN) shows an Average True Range (ATR) of 2.14 and an Enterprise Value of 358.27B. Its average trading volume over the past 3 months is 2.86M, indicating liquidity. These fundamental metrics provide insight into BMRN's underlying financial health and market activity.
BioMarin Pharmaceutical Inc. (BMRN) technical indicators as of December 23, 2025: the SMA 20 is 8.89%, SMA 50 at 10.29%, and SMA 200 at 2.42%. The RSI 14 value is 65.44, suggesting its current momentum. These technical analysis signals help assess BMRN's price trends and potential future movements.
BioMarin Pharmaceutical Inc. (BMRN) stock performance overview as of December 23, 2025: The 52-week high is $73.51 (currently -19.36% below), and the 52-week low is $50.76 (currently 16.78% above). Over the past year, BMRN's performance is -9.55%, compared to the S&P 500's 10.56% change.
According to market data, BioMarin Pharmaceutical Inc. (BMRN) stock's recent performance metrics show that over the last month, BMRN is 12.79%, with a Year-to-Date (YTD) performance of -9.81%. Over the past year, the stock has seen a -9.55% change. These figures summarize BMRN's price movements across various periods, reflecting its historical returns.
According to current financial data, BMRN stock's P/E (TTM) ratio is 22.43, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for BMRN, including P/S (3.77), P/B (1.93), and P/FCF (14.05), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.